Cargando…
Pupillometric analysis for assessment of gene therapy in Leber Congenital Amaurosis patients
BACKGROUND: Objective techniques to assess the amelioration of vision in patients with impaired visual function are needed to standardize efficacy assessment in gene therapy trials for ocular diseases. Pupillometry has been investigated in several diseases in order to provide objective information a...
Autores principales: | Melillo, Paolo, Pecchia, Leandro, Testa, Francesco, Rossi, Settimio, Bennett, Jean, Simonelli, Francesca |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3526436/ https://www.ncbi.nlm.nih.gov/pubmed/22812667 http://dx.doi.org/10.1186/1475-925X-11-40 |
Ejemplares similares
-
Gene Therapy for Leber's Congenital Amaurosis is Safe and Effective Through 1.5 Years After Vector Administration
por: Simonelli, Francesca, et al.
Publicado: (2009) -
Identifying fallers among ophthalmic patients using classification tree methodology
por: Melillo, Paolo, et al.
Publicado: (2017) -
Molecular characterization of Leber congenital amaurosis in Koreans
por: Seong, Moon-Woo, et al.
Publicado: (2008) -
Treatment Potential for LCA5-Associated Leber Congenital Amaurosis
por: Uyhazi, Katherine E., et al.
Publicado: (2020) -
NMNAT1 mutations cause Leber congenital amaurosis
por: Falk, Marni J, et al.
Publicado: (2012)